Found: 28
Select item for more details and to access through your institution.
Inhibition of the Wnt Signalling Pathway: An Avenue to Control Breast Cancer Aggressiveness.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9069, doi. 10.3390/ijms21239069
- By:
- Publication type:
- Article
An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 5, p. 572, doi. 10.1002/ijc.2910620514
- By:
- Publication type:
- Article
Distinct pattern of HSP72 and monomeric laminin receptor expression in human lung cancers infiltrated by γ/δ T lymphocytes.
- Published in:
- International Journal of Cancer, 1994, v. 57, n. 4, p. 486, doi. 10.1002/ijc.2910570408
- By:
- Publication type:
- Article
Intratumor lactate levels reflect HER2 addiction status in HER2‐positive breast cancer.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 2, p. 1768, doi. 10.1002/jcp.27049
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211006960
- By:
- Publication type:
- Article
Identification of Relevant Conformational Epitopes on the HER2 Oncoprotein by Using Large Fragment Phage Display (LFPD).
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0058358
- By:
- Publication type:
- Article
The Human Splice Variant Λ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018727
- By:
- Publication type:
- Article
Impact of in vitro SARS-CoV-2 infection on breast cancer cells.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63804-3
- By:
- Publication type:
- Article
Immunological and pathobiological roles of fibulin-1 in breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- Correction Notice
Immunological and pathobiological roles of fibulin-1 in breast cancer.
- Published in:
- Oncogene, 2004, v. 23, n. 12, p. 2153, doi. 10.1038/sj.onc.1207323
- By:
- Publication type:
- Article
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4778, doi. 10.3390/cancers13194778
- By:
- Publication type:
- Article
The d16HER2 Splice Variant: A Friend or Foe of HER2-Positive Cancers?
- Published in:
- Cancers, 2019, v. 11, n. 7, p. 902, doi. 10.3390/cancers11070902
- By:
- Publication type:
- Article
Ectopic expression of pRb2/p130 suppresses the tumorigenicity of the c-erbB-2-overexpressing SKOV3 tumor cell line.
- Published in:
- Oncogene, 1999, v. 18, n. 3, p. 651, doi. 10.1038/sj.onc.1202363
- By:
- Publication type:
- Article
p185.
- Published in:
- International Journal of Cancer, 2000, v. 87, n. 2, p. 186, doi. 10.1002/1097-0215(20000715)87:2<186::AID-IJC5>3.0.CO;2-1
- By:
- Publication type:
- Article
Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.
- Published in:
- Journal of Cellular Physiology, 2012, v. 227, n. 2, p. 658, doi. 10.1002/jcp.22773
- By:
- Publication type:
- Article
Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility.
- Published in:
- Journal of Cellular Physiology, 2010, v. 225, n. 1, p. 256, doi. 10.1002/jcp.22257
- By:
- Publication type:
- Article
SEL1L a multifaceted protein playing a role in tumor progression<FNR></FNR><FN>Monica Cattaneo and Rosaria Orlandi have equal merit for the work. </FN>.
- Published in:
- Journal of Cellular Physiology, 2006, v. 208, n. 1, p. 23, doi. 10.1002/jcp.20574
- By:
- Publication type:
- Article
HER-2: A biomarker at the crossroads of breast cancer immunotherapy and molecular medicineSerenella M. Pupa and Elda Tagliabue contributed equally to this work.
- Published in:
- Journal of Cellular Physiology, 2005, v. 205, n. 1, p. 10, doi. 10.1002/jcp.20387
- By:
- Publication type:
- Article
New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary bladder, and prostate tumors (The Fourth Joint International Workshop Histologic and Cytologic Characterization of Human Tumors: New Basic Discoveries and Frontiers in Diagnosis, Prognosis, and Prediction of Response to Therapy in Human Thyroid, Urinary Bladder, and Prostate Tumors was held at Lacco Ameno d'Ischia, Italy, on April 30May 3 2003, under the sponsorship of: Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Sbarro Health Research Organization, Azienda Sanitaria Locale Napoli 1, Italian Tumor Society, General Hospital A. Cardarelli, Azienda Ospedaliera D. Cotugno, Second University of Naples, University of Siena, University of Pennsylvania Health System and Thomas Jefferson University.)
- Published in:
- Journal of Cellular Physiology, 2004, v. 198, n. 3, p. 343, doi. 10.1002/jcp.10444
- By:
- Publication type:
- Article
New insights into the role of extracellular matrix during tumor onset and progression.
- Published in:
- Journal of Cellular Physiology, 2002, v. 192, n. 3, p. 259, doi. 10.1002/jcp.10142
- By:
- Publication type:
- Article
Role of HER2 gene overexpression in breast carcinoma.
- Published in:
- Journal of Cellular Physiology, 2000, v. 182, n. 2, p. 150, doi. 10.1002/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E
- By:
- Publication type:
- Article
The Emerging Role of the Microbiota in Breast Cancer Progression.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 15, p. 1945, doi. 10.3390/cells12151945
- By:
- Publication type:
- Article
Cancer Stem Cells: Devil or Savior—Looking behind the Scenes of Immunotherapy Failure.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 3, p. 555, doi. 10.3390/cells9030555
- By:
- Publication type:
- Article
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
- Published in:
- Cellular Oncology (2211-3428), 2023, v. 46, n. 3, p. 661, doi. 10.1007/s13402-023-00769-x
- By:
- Publication type:
- Article
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2022, v. 45, n. 2, p. 257, doi. 10.1007/s13402-022-00663-y
- By:
- Publication type:
- Article
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 6, p. 815, doi. 10.1007/s13402-019-00464-w
- By:
- Publication type:
- Article